NCT05421923View on ClinicalTrials.gov

The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 24, 2022

Primary Completion Date

October 5, 2022

Study Completion Date

October 5, 2022

Conditions
Healthy
Interventions
DRUG

SR1375 capsules

Ascending single and multiple doses of SR1375 orally

OTHER

Placebo

Ascending single and multiple doses of Placebo orally

Trial Locations (1)

Unknown

Phase I clinical laboratory of Huashan Hospital, Shanghai

All Listed Sponsors
lead

Shanghai SIMR Biotechnology Co., Ltd.

INDUSTRY